HR 7838
116th Congress
House
Health
Cardiovascular and respiratory health
Child health
Emergency medical services and trauma care
Health facilities and institutions
Health programs administration and funding
Home and outpatient care
Infectious and parasitic diseases
Inflation and prices
Prescription drugs
Public contracts and procurement
To provide for certain temporary waivers with respect to the 340B drug discount program due to the COVID-19 public health emergency, and for other purposes.
Introduced: July 29, 2020
Introduced by:
Matsui, Doris O.
Democratic
· California
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 29, 2020
Referred to the House Committee on Energy and Commerce.
Jul 29, 2020
Introduced in House
Plain-English summary
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. For example, the bill waives the required minimum proportion of low-income patients served for hospitals that were participating or applied to participate in the program prior to the COVID-19 emergency.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1